Pharmacy Medical News about Chronic Pain

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

FDA Approves EMBEDA for Management of Moderate to Severe Chronic Pain
King Pharmaceuticals, 08/14/09

King Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved EMBEDA Extended Release Capsules for oral use, a long–acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around–the–clock opioid analgesic is needed for an extended period of time. EMBEDA is the first FDA–approved long–acting opioid that is designed to reduce drug liking and euphoria when tampered with by crushing or chewing.

<< Previous
Array BioPharma Reports Positive Results of Its Oral Glucokinase...

Next >>
CMS announces policy and payment rate changes for inpatient stays...

Chronic pain alters the structure of the brain
Schmerz, 10/20/09 Relevance Score: 72%

Acute postoperative pain as a risk factor for chronic pain after surgery
European Journal of Pain, 11/12/09 Relevance Score: 71%

Brain Gray Matter Decrease in Chronic Pain Is the Consequence and Not the Cause of Pain
Journal of Neuroscience, 11/10/09 Relevance Score: 71%

Chronic pain-related changes in endogenous opioid analgesia: A case report
Pain, 10/16/09 Relevance Score: 71%

Prognosis for patients with chronic low back pain: inception cohort study
British Medical Journal, 10/09/09 Relevance Score: 71%